I. Introduction
Sleep-disordered breathing (SDB) is a group of common disorders that affect up to 20% of the population [1]. Its prevalence has substantially increased over the past two decades: an increase of more than 14% in the North-American adult population [2]. The most prominent disorder among this group is obstructive sleep apnea (OSA), which is characterized by recurrent events of partial or complete collapse of the upper airway during sleep (i.e., hypopnea and apnea). OSA can lead to excessive daytime sleepiness, cardiovascular morbidity, and death [3]. Severity of OSA is measured by the apnea-hypopnea index (ARI), which is the average number of apnea and hypopnea events per hour of sleep.